Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Extension of Etanercept in Ankylosing Spondylitis
NCT00356356Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2002
- Primary completion
- Aug 2006
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in ankylosing spondylitis (AS), sponsored by Amgen. Started Apr 2002; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00356356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356356.